These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 27112240)

  • 1. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
    Irani MS; Karafin MS; Ernster L
    J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
    Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
    Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limiting the extent of a delayed hemolytic transfusion reaction with automated red blood cell exchange.
    Tormey CA; Stack G
    Arch Pathol Lab Med; 2013 Jun; 137(6):861-4. PubMed ID: 23721278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.
    Jajosky RP; Lumm WC; Wise SC; Bollag RJ; Shikle JF
    Immunohematology; 2017 Jun; 33(2):73-75. PubMed ID: 28657766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemolytic transfusion reaction caused by anti-Yt
    Raos M; Thornton N; Lukic M; Golubic Cepulic B
    Immunohematology; 2021 Mar; 37(1):13-17. PubMed ID: 33962487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
    Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
    Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemolytic transfusion reaction due to anti-Le(b).
    Irani MS; Figueroa D; Savage G
    Transfusion; 2015 Oct; 55(10):2486-8. PubMed ID: 26018602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: massive postpartum transfusion of Jr(a+) red cells in the presence of anti-Jra.
    Yuan S; Armour R; Reid A; Abdel-Rahman KF; Rumsey DM; Phillips M; Nester T
    Immunohematology; 2005; 21(3):97-101. PubMed ID: 16178666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute extravascular hemolytic transfusion reaction due to anti-Kpa antibody missed by electronic crossmatch.
    Padmore R; Berardi P; Erickson K; Desjardins D; Giulivi A; Tokessy M; Neurath D; Saidenberg E
    Transfus Apher Sci; 2014 Oct; 51(2):168-71. PubMed ID: 25175412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delayed hemolytic transfusion reaction caused by an anti-U].
    Taliano V; Fleury M; Pichette R; Lamothe M; Décary F
    Rev Fr Transfus Hemobiol; 1989 Feb; 32(1):17-26. PubMed ID: 2719776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of mediators of systemic inflammatory response syndrome in the course of a severe delayed hemolytic transfusion reaction caused by anti-D.
    von Zabern I; Ehlers M; Grunwald U; Mauermann K; Greinacher A
    Transfusion; 1998 May; 38(5):459-68. PubMed ID: 9633559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell transfusion in patients with anti-Yt
    Wong SM; Cawthorne T; Dennington PM; Hong FS
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe delayed hemolytic transfusion reaction secondary to anti-At(a).
    Cash KL; Brown T; Sausais L; Uehlinger J; Reed LJ
    Transfusion; 1999 Aug; 39(8):834-7. PubMed ID: 10504118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Jk
    Kay B; Poisson JL; Tuma CW; Shulman IA
    Transfusion; 2016 Dec; 56(12):2973-2979. PubMed ID: 27596036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion.
    Liepkalns JS; Cadwell CM; Stowell SR; Hod EA; Spitalnik SL; Zimring JC
    Transfusion; 2013 Jun; 53(6):1319-27. PubMed ID: 23033973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolysis due to the simultaneous occurrence of passenger lymphocyte syndrome and a delayed hemolytic transfusion reaction in a liver transplant patient.
    Jacobs LB; Shirey RS; Ness PM
    Arch Pathol Lab Med; 1996 Jul; 120(7):684-6. PubMed ID: 8757477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
    Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L
    Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.